MTOR and psoriasis: Suppression of PI3K/AKT/mTOR (mammalian target of rapamycin) signaling has also been suggested in the treatment of psoriasis [58] and the antioxidant protein, HO-1, may mitigate IMQ-induced psoriasis-like inflammation by blocking the STAT3 signal [59].